ClinicalTrials.gov
ClinicalTrials.gov Menu

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00484536
Recruitment Status : Terminated (The study was discontinued due to unfavorable interim analysis)
First Posted : June 11, 2007
Last Update Posted : September 12, 2011
Sponsor:
Collaborator:
Biogen
Information provided by (Responsible Party):
UCB Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : July 2010
  Certification/Extension First Submitted : January 20, 2011